Cutaneous and other vasculitides are specific inflammations of the blood vessel wall that can take place in any organ system of the body including the skin. Vasculitis has been traditionally divided according to the size of the vessel involved (small, medium, and large). Vasculitis is more of a reaction pattern rather than a specific disease entity. Therefore, the clinical presentation of vasculitis (most commonly palpable purpura on the lower extremities) dictates a thorough history, review of systems, and a meticulous physical examination. The diagnosis of vasculitis relies also on the histopathological and immunofluorescence studies. Wound care specialist may face with vasculitis-associated ulcers along with a spectrum of other cutaneous presentations associated with vasculitis. The focus of this article is to update the types, etiology, pathogenesis, and management options for cutaneous vasculitis.
McCourtCDutzJP. Making necrotizing vasculitis simple. J Cutan Med Surg. 2013;17(suppl 1):S40-S46.
3.
LakdawalaNFedelesF. Vasculitis: Kids are not just little people. Clin Dermatol. 2017Nov-Dec; 35(6):530-540. doi:10.1016/j.clidermatol.2017.08.004. Epub2017Aug4.
4.
LavaSAGMilaniGPFossaliEFSimonettiGDAgostoniCBianchettiMG. Cutaneous manifestation of small-vessel leukocytoclastic vasculitides in childhood. Clin Rev Allergy Immunol. 2017;53:439-451.
5.
González-GayMALópez-MejíasRPinaTBlancoRACastañedaS.IgA vasculitis: genetics and clinical and therapeutic management. Curr Rheumatol Rep. 2018;20:24. doi:10.1007/s11926-018-0735-3
6.
GyselbrechtLDe KeyserFOngenaeKNaeyaertJMPraetMVeysEM.Etiological factors and underlying conditions in patients with leukocytoclastic vasculitis. Clin Exp Rheumatol. 1996;14:665-668.
7.
EafECallenJP.Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol. 1984;120:484-489.
Martinez-TaboadaVMBlancoRGarcia-FuentesMRodriguez-ValverdeV.Clinical features and outcome of 95 patients with hypersensitivity vasculitis. Am J Med. 1997;102:186-191.
13.
SaisGVidallerAJucglaAServitjeOCondomEPeyriJ.Prognostic factors in leukocytoclastic vasculitis. A clinicopathologic study of 160 patients. Arch Dermatol. 1998;134:309-315.
ForbessLBannykhS.Polyarteritis nodosa. Rheum Dis Clin North Am. 2015;41:33-46.
16.
DabiriGDamstetterEChangYEbotEBPowersJGPhillipsT.Coagulation disorders and their cutaneous presentations: diagnostic work-up and treatment. J Am Acad Dermatol. 2016;74:795-804.
17.
SwerlickRALawleyTJ.Cutaneous vasculitis: its relationship to systemic disease. Med Clin North Am. 1989;73:1221-1235.
18.
DavisMDPDaoudMSKirbyBGibsonLERogersRS3rd. Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol. 1998;38(6pt 1):899-905.
19.
ChenKRCarlsonJA.Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9:71-92.
20.
QiuOChanTLuenMCruzJEHermes-DeSantisER. Use of nitroglycerin ointment to treat primary and secondary Raynaud’s phenomenon: a systematic literature review [published online August 22, 2018]. Rheumatol Int. doi:10.1007/s00296-018-4119-9
21.
GiuggioliDManfrediALumettiFSebastianiMFerriC.Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature. Semin Arthritis Rheum. 2015;44:518-526.
22.
CarlsonJAChenKR.Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol. 2007;29:32-43.
23.
ZaxRHHodgeSJCallenJP.Cutaneous leukocytoclastic vasculitis. Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. Arch Dermatol. 1990;126:69-72.
GibsonLE.Cutaneous vasculitis: approach to diagnosis and systemic associations. Mayo Clin Proc. 1990;65:221-229.
26.
SanchezNVan HaleHMSuWP.Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings of 101 cases. Arch Dermatol. 1985;121:220-224.
27.
RussellJPGibsonLE.Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment. Int J Dermatol. 2006;45:3-13.
28.
HelanderSDDe CastroFRGibsonLE.Henoch-Schönlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leukocytoclastic vasculitis. Acta Derm Venereol. 1995;75:125-129.
29.
LottiTGhersetichIComacchiCJorizzoJL.Cutaneous small-vessel vasculitis. J Am Acad Dermatol. 1998;39(5pt 1):667-690.
30.
Ortiz-SanjuánFBlancoRHernándezJLet al. Drug-associated cutaneous vasculitis: study of 239 patients from a single referral center. J Rheumatol. 2014;41:2201-2207.
31.
SaisGVidallerAJucglaAGallardoFPeyríJ. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol. 1995;131:1399-1402.
32.
DasgebBKornreichDMcGuinnKOkonLBrownellISackettDL.Colchicine: an ancient drug with novel applications. Br J Dermatol. 2018;178:350-356. doi:10.1111/bjd.15896
33.
ZhuYIStillerMJ.Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001;45:420-434.
FredenbergMFMalkinsonFD.Sulfone therapy in the treatment of leukocytoclastic vasculitis: report of three cases. Dermatology. 1987;16:772-778.
36.
FortsonJSZoneJJHammondMEGroggelGC.Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone. J Am Acad Dermatol. 1986;15(5pt 2):1137-1142.
37.
LoriceraJBlancoROrtiz-SanjuanFet al. Single-organ cutaneous small-vessel vasculitis according to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides: a study of 60 patients from a series of 766 cutaneous vasculitis cases. Rheumatology (Oxford). 2015;54:77-82.
38.
PastuszczakMCelińska-LöwenhoffMSułowiczJWojas-PelcAMusiałJ.Clinical study on single-organ cutaneous small vessels vasculitis (SoCSVV). Medicine (Baltimore). 2017;96:e6376.
39.
ChenJYMaoJH.Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr. 2015;11:29-34.
40.
Audemard-VergerATerrierBDechartresAet al. Characteristics and management of IgA casculitis (Henoch-Schönlein) in adults: data from 260 patients included in a French Multicenter Retrospective Survey. Arthritis Rheumatol. 2017;69:1862-1870. doi:10.1002/art.40178
41.
JachietMFlageulBDerouxAet al; French Vasculitis Study Group. The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients. Arthritis Rheumatol. 2015;67:527-534.
42.
LoriceraJCalvo-RíoVMataCet al. Urticarial vasculitis in northern Spain: clinical study of 21 cases. Medicine (Baltimore). 2014;93:53-60.
Yamazaki-NakashimadaMADuran-McKinsterCRamírez-VargasNHernandez-BautistaV. Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child. Pediatr Dermatol. 2009;26:445-447.
45.
BredaLFranchiniSMarzettiVChiarelliF.Intravenous immunoglobulins for cutaneous polyarteritis nodosa resistant to conventional treatment. Scand J Rheumatol. 2016;45:169-170.
46.
ValorLMonteagudoIde la TorreIet al. Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept. Mod Rheumatol. 2014;24:688-689.
47.
Campanilho-MarquesRRamosFCanhãoHFonsecaJE.Remission induced by infliximab in a childhood polyarteritis nodosa refractory to conventional immunosuppression and rituximab. Joint Bone Spine. 2014;81:277-278.
48.
MarieIMirandaSGirszynNSoubraneJCVandhuickTLevesqueH.Intravenous immunoglobulins as treatment of severe cutaneous polyarteritis nodosa. Intern Med J. 2012;42:459-462.
49.
RibiCCohenPPagnouxCet al; French Vasculitis Study Group. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum. 2010;62:1186-1197.
50.
JonesRBTervaertJCWHauserTet al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363:211-220.
51.
StoneJHMerkelPASpieraRet al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221-232.
52.
PagnouxCMahrAHamidouMAet al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359:2790-2803.
53.
TimlinHLeeSMMannoRLSeoPGeethaD.Rituximab for remission induction in elderly patients with ANCA-associated vasculitis. Semin Arthritis Rheum. 2015;45:67-69.
54.
Aguirre-ValenciaDPosso-OsorioIBravoJCBonilla-AbadíaFTobónGJCañasCA.Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Clin Rheumatol. 2017;36:2159-2162. doi:10.1007/s10067-017-3780-9
55.
MetzlerCMiehleNMangerKet al; German Network of Rheumatic Diseases. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener’s granulomatosis. Rheumatology (Oxford). 2007;46:1087-1091.
56.
MacdonaldJZhongTLazarescuAGanBSHarthM.Vasculitis associated with the use of leflunomide. J Rheumatol. 2004;31:2076-2078.
57.
RobertsJCliffordA.Update on the management of giant cell arteritis. Ther Adv Chronic Dis. 2017;8:69-79.
58.
AbisrorNMekinianALavigneCet al; Club Rhumatismes et Inflammation, and SNFMI. Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review. Autoimmun Rev. 2013;12:1143-1149.
59.
AlaviASibbaldRGKirsnerRS.Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm. J Dermatolog Treat. 2018;29:383-384. doi:10.1080/09546634.2017.1385719
60.
ScheinbergMABezerraJBAlmeidaFASilveiraLA.Cutaneous necrotising vasculitis induced by levamisole. Br Med J. 1978;1:408.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
